A Study Assessing Short-Course Radiation Therapy Plus Chemotherapy for Endometrial Cancer

Full Title

A Feasibility Study of Integrated Delivery of Hypofractionated Pelvic IMRT with Carboplatin and Paclitaxel in Stage III Copy-Number Low and Copy-Number High Subtypes of Endometrial Cancer

Purpose

After endometrial cancer surgery, there is a risk that the cancer will come back. Combining a shorter course of radiation treatment with chemotherapy may decrease the chance of endometrial cancer recurring.

In this study, participants will receive one week of radiation therapy (instead of the usual five weeks) plus chemotherapy with carboplatin and paclitaxel, which are given intravenously (by vein). Researchers are doing this study to determine if this combination of therapies is practical, meaning that most participants can complete the treatment schedule.

Contact

For more information and to ask about eligibility for this study, please contact the office of Dr. Kaled Alektiar at 212-639-7981.